Direct method for the measurement of low-density lipoprotein cholesterol levels in patients with chronic renal disease: A comparative assessment

Nephron

Volumn 79, Issue 2, 1998, Pages 154-161

  Akanji, Abayomi O ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Atherosclerosis, Arabs; Chronic renal failure, dialysis; Low density lipoprotein cholesterol; Nephrotic syndrome

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIET RESTRICTION; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; CHEMISTRY, CLINICAL; CHILD; CHOLESTEROL, LDL; HUMANS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; MATHEMATICS; MIDDLE AGED; NEPHROTIC SYNDROME; REGRESSION ANALYSIS;

EID: 0031831540     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045018     Document Type: Article

References (15)

1. Appel GB, Valeri A, Appel AS, Blum C: The hyperlipidaemia of the nephrotic syndrome. Am J Med 1989;87:S45N-S50N.
2. Green D, Stone NJ, Krumlovsky FA: Putative atherogenic factors in patients with chronic renal failure. Prog Cardiovasc Dis 1983;26:133-144.
3. Tsukamoto Y, Kokubo T, Hori A, Moriya R, Kobayashi Y: Lipoprotein derangement during steroid treatment in minimal-change nephrotic syndrome. Nephron 1996;73:606-612.
4. Keane WF, Kasiske DL, O'Donnel MP: Lipids and progressive glomerulosclerosis: A model analogous to atherosclerosis. Am J Nephrol 1986;8:261-267.
5. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
6. Hunninghake DB: Diagnosis and treatment of lipid disorders. Med Clin North Am 1994;78:247-257.
7. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative centrifuge. Clin Chem 1972;18:499-502.
8. Orchard TJ: Dyslipoproteinaemia and diabetes. Endocrinol Metab Clin North Am 1990;19:361-379.
9. Reaven GM: Abnormal lipoprotein metabolism in non-insulin dependent diabetes mellitus. Am J Med 1987;83:31-40.
10. Rubies-Prat J, Reverter JL, Senti M, Pedro-Botet J, Salinas I, Lucas A, Nogues X, Sanmarti A: Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care 1993;16:1081-1086.
11. Jialal I, Hirany SH, Deveraj S, Sherwood TA: Comparison of an immunoprecipitation method for direct measurement of LDL cholesterol with beta-quantification (ultracentrifugation). Am J Clin Pathol 1995;104:76-81.
12. McNamara JR, Cole TG, Contois JH, Ferguson CA, Ordovas JM, Schaefer EJ: Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum. Clin Chem 1995;41:232-240.
13. Hirany S, Li D, Jialal I: A more valid measurement of low-density lipoprotein cholesterol in diabetic patients. Am J Med 1997;102:48-53.
14. Attman PO, Alaupovic P: Lipid and apolipoprotein profiles of uraemic dyslipoproteinaemia: Relation to renal function and dialysis. Nephron 1991;57:401-410.
15. SPSS-X: User's guide, ed 2. New York, McGraw Hill, 1986.